Concord Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE858L01010
  • NSEID:
  • BSEID: 538965
INR
77.10
-0.83 (-1.07%)
BSENSE

Jun 18

BSE+NSE Vol: 1.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryConcord Drugs VS Pharmaceuticals & Biotechnology
 
calendar-icon
calendar-icon
1D
-1.07%
0.15%
1W
-1.83%
4.66%
1M
-3.02%
2.6%
YTD
-6.52%
-9.33%
1Y
151.8%
-5.12%
3Y
169.3%
21.91%
5Y
130.49%
47.62%
10Y
42.78%
190.21%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.03%
0%
3.03%
6 Months
-6.34%
0%
-6.34%
1 Year
151.8%
0%
151.8%
2 Years
97.9%
0%
97.9%
3 Years
169.3%
0%
169.3%
4 Years
208.4%
0%
208.4%
5 Years
130.49%
0%
130.49%

Concord Drugs for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
10.96%
3
Quartile
quartile-3
Dec-Mar
-14.85%
1
Quartile
quartile-1
Sep-Dec
23.66%
1
Quartile
quartile-1
YTD
154.51%
1
Quartile
quartile-1
2025
117.05%
4
Quartile
quartile-4
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
10.96%
2
Quartile
quartile-2
Dec-Mar
-14.85%
1
Quartile
quartile-1
Sep-Dec
23.66%
1
Quartile
quartile-1
YTD
154.51%
1
Quartile
quartile-1
2025
117.05%
4
Quartile
quartile-4
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
10.96%
2
Quartile
quartile-2
Dec-Mar
-14.85%
1
Quartile
quartile-1
Sep-Dec
23.66%
1
Quartile
quartile-1
YTD
154.51%
1
Quartile
quartile-1
2025
117.05%
4
Quartile
quartile-4
2024
-36.37%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."